Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Net Cash Flow (2018 - 2025)

Dna X (SONM) has disclosed Net Cash Flow for 8 consecutive years, with $131000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Cash Flow rose 124.26% year-over-year to $131000.0, compared with a TTM value of -$6.9 million through Sep 2025, down 839.35%, and an annual FY2024 reading of -$4.1 million, down 6.24% over the prior year.
  • Net Cash Flow was $131000.0 for Q3 2025 at Dna X, up from -$109000.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $7.5 million in Q2 2022 and bottomed at -$8.2 million in Q1 2021.
  • Average Net Cash Flow over 5 years is -$1.1 million, with a median of -$400000.0 recorded in 2023.
  • The sharpest move saw Net Cash Flow surged 207.25% in 2022, then plummeted 2126.21% in 2025.
  • Year by year, Net Cash Flow stood at $1.0 million in 2021, then tumbled by 316.16% to -$2.3 million in 2022, then surged by 82.31% to -$400000.0 in 2023, then crashed by 829.25% to -$3.7 million in 2024, then surged by 103.52% to $131000.0 in 2025.
  • Business Quant data shows Net Cash Flow for SONM at $131000.0 in Q3 2025, -$109000.0 in Q2 2025, and -$3.2 million in Q1 2025.